← Back to Research Radar
Academic Publication Academic Publication

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

342
Citations
June 1, 2024
Published Date

Research Abstract & Technology Focus

No abstract provided for this literature.
eular recommendations management psoriatic arthritis pharmacological
Read Full Literature

AI Semantic Synergy Context

Connecting this academic literature to real-world market discussions and products.

crossref.org › academic paper
51%
🔥

EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update

No description provided.
crossref.org › academic paper
0%

EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis: 2023 update

No description provided.
crossref.org › academic paper
0%

Final Results From the Randomized Phase III ASCENT Clinical Trial in Metastatic Triple-Negative Breast Cancer and Association of Outcomes by Human Epidermal Growth Factor Receptor 2 and Trophoblast Cell Surface Antigen 2 Expression

Clinical trials frequently include multiple end points that mature at different times. The initial report, typically based on the primary end point, may be published when key planned co-primary or ...
crossref.org › academic paper
0%

2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

AIM: The “2024 ACC/AHA/AACVPR/APMA/ABC/SCAI/SVM/SVN/SVS/SIR/VESS Guideline for the Management of Lower Extremity Peripheral Artery Disease” provides recommendations to guide clinicians ...
crossref.org › academic paper
0%

Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les traitements de l'humeur et de l'anxiété (CANMAT) 2023 : Mise à jour des lignes directrices cliniques pour la prise en charge du trouble dépressif majeur chez les adultes

Background The Canadian Network for Mood and Anxiety Treatments (CANMAT) last published clinical guidelines for the management of major depressive disorder (MDD) in 2016. Owing ...

Frequently Asked Questions (FAQ)

Curated market intelligence mapped to this research.

What is the core focus of the research titled 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update'?

This literature focuses on:

Are there open-source GitHub repositories related to EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update?

Yes, open-source projects like EKKOLearnAI/hermes-web-ui (Web dashboard for Hermes Agent — multi-platform AI chat, session management, scheduled jobs, usage analytics & channel configuration (Telegram, Dis...) are actively building upon these concepts.

Which startups are commercializing the technology behind EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update?

Products like JusticeFlow - AI-Powered Legal Practice are bringing this to market. Their focus is: Legal Practice Management with AI-Powered Intelligence.

What other academic literature is closely related to 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update'?

Yes, highly correlated activity was mapped. An entry titled 'EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2023 update' discusses this: No description provided.

Cite this Market Intelligence Report

Reference our AI-mapped synergy between this research and the commercial market to instantly build authority.

Commercial Realization

Startups and Open Source tools heavily associated with the concepts explored in this paper.

Associated Media Narrative